(Pharmaceutical) industry
Pharma, production, and laboratory environments
Compliance and operational pressure simultaneously. Mobile validation and keyless access are possible, but only where it improves the process. Issuance is often hybrid: fixed roles assigned to the person and temporary access controlled.
Policy in brief
-
Mobile validator: yes
-
Keyless to the lock: sometimes
-
Flex (wired): yes
-
Default issuance: hybrid
-
Integrations: sometimes
-
Publication: industry only, no company names
Context and assets
Many roles across departments and zones. Not everyone needs to be proficient in everything. Audits require demonstrable zoning, exception management, and clear processes.
Recommended setup
Rights-based access with key as the basis and zoning
Key-based access remains the basis for critical areas and assets. Zoning by process department and criticality.
Keyless selective
Keyless where key management becomes disproportionately burdensome or temporary access is dominant. Not everything needs the same technology.
Hybrid issuance
Fixed roles: hands-on.
Contractors and temporary: vault or controlled process with limited validity.
Flex (wired)
Flex for wired I/O and internal process connections when this management is supported.
Software and hosting
CAW Enterprise as the management base. EU-hosted shared or dedicated depending on scale and governance. On-prem upon strict IT requirement.
Pitfalls within the sector
Keyless
Keyless as default, while keyed access is more robust.
Zones
Skipping zoning, making audits and incident handling more burdensome